News

Hosted on MSN7mon
Epilepsy drug could reduce major sleep apnea symptoms, new trial shows
A new study presented at the European Respiratory Society Conference in Vienna suggests that popular epilepsy drug Sulthiame may reduce major Obstructive Sleep Apnea (OSA) symptoms. According to ...
Hosted on MSN12mon
Anti-Epilepsy Drug Improves Sleep Apnea Symptoms in Mid-Stage Trial
SAN DIEGO -- The anti-epilepsy drug sulthiame significantly improved symptoms of moderate-to-severe obstructive sleep apnea (OSA), a phase ... The high responders may make up 30%-40% of patients ...
Rheumatology Advisor5d
How GLP-1s Could Help People Sleep Better — Beyond Weight Loss
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
MedCity News2d
Sleep Apnea Relief in a Pill: Apnimed Drug’s Phase 3 Data Set Stage for FDA Submission
Apnimed’s approach to obstructive sleep ... reduce [apnea-hypopnea index] in one pharmaceutical formulation, we believe IHL-42X may have therapeutic benefit at lower doses of each constituent ...
Hosted on MSN7mon
Drug treatment shows promise for dangerous snoring condition, obstructive sleep apnea
Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnea (OSA ... and they may wake up several times.
WNEM Saginaw on MSN2mon
Medical milestone: First drug for sleep apnea
Finally, there may be another option for Roger — a drug ... sleep apnea because of the weight loss, or does it change brain ...
Hosted on MSN1mon
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...